XRTX Stock Analysis: Buy, Sell, or Hold?
XRTX - XORTX Therapeutics Inc. Common Stock
$2.07
-0.05 (-2.36%)
▼
5d:
-4.12%
30d:
-5.91%
90d:
+388.21%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When XRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XRTX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: XRTX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.62
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.63
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: XRTX is currently trading at $2.07, which is considered oversold relative to its 30-day fair value range of $2.11 to $2.27. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.9) compared to its historical average (1.7). At these levels, the market is pricing in 4.1% annual earnings growth.
Technical Outlook: Technically, XRTX is in a strong uptrend. The price is currently testing key support at $2.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.04 (+578.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XRTX is in a strong uptrend. The price is currently testing key support at $2.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.04 (+578.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.11 -
$2.27
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 578.1% below Wall St target ($14.04)
- BULLISH: Expecting earnings turnaround to 4.1% growth with None% revenue growth
Trading Range Analysis
30-Day Trading Range
$2.11 -
$2.27
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.09
Resistance Level
$2.60
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.88
Wall Street Target
$14.04
(+578.1%)
Earnings Growth (YoY)
-97.2%
Valuation Premium vs History
+4.1% premium
PE vs Historical
1.9 vs 1.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$2.15
(+4%)
2-Year Target
$2.24
(+8%)
3-Year Target
$2.34
(+13%)
3-Yr Target (if PE normalizes)
(PE: 2→2)
PE COMPRESSION
$2.11
(+2%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 05, 2026 12:52 AM ET
Data refreshes hourly during market hours. Next update: 1:52 AM
Data refreshes hourly during market hours. Next update: 1:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$291 | 63 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$46 | 61 BUY |
